Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | DC tumor cell lysate vaccine |
Synonyms | |
Therapy Description |
DC tumor cell lysate vaccine is a cancer vaccine comprised of autologous dendritic cells pulsed with tumor cell lysate, which potentially induces anti-tumor immune response (PMID: 15256471). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
DC tumor cell lysate vaccine | Dendritic Cell Tumor Cell Lysate Vaccine|ATL-DC | DC tumor cell lysate vaccine is a cancer vaccine comprised of autologous dendritic cells pulsed with tumor cell lysate, which potentially induces anti-tumor immune response (PMID: 15256471). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04157127 | Phase I | DC tumor cell lysate vaccine | Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma (DECIST) | Active, not recruiting | USA | 0 |